One of the main challenges in oral disease is prevention of bacterial infections considering antibiotic resistance as a result of frequent use of conventional antibiotics. A natural alternative to these… Click to show full abstract
One of the main challenges in oral disease is prevention of bacterial infections considering antibiotic resistance as a result of frequent use of conventional antibiotics. A natural alternative to these chemical antibiotics is antimicrobial peptide (AMP). LL37, a helical and amphipathic peptide with 37 amino acid residues, is the only cathelicidin-derived form of AMPs in humans that has a broad spectrum of antimicrobial activity (Majewski et al. in Cent Eur J immunol 43(4):453–457, https://doi.org/10.5114/ceji.2018.81355 , 2018). In this study a bi-functional fusion peptide was designed, which consisted of LL-37 peptide linked to a hydroxyapatite (HA) binding peptide through a GGGGS linker. The fusion peptide antimicrobial activity was assessed against both gram-positive and gram-negative bacteria by the microtiter plate method and minimum inhibitory concentrations of 250 µg/ml and 125 µg/ml were obtained for Streptococcus mutans and Escherichia coli , respectively. The binding affinity of the HABP-LL37 fusion peptide to HA-surfaces was confirmed by the peptide release test using the spectrometer method. The HABP-LL37 fusion peptide immobilization on HA surfaces was done using a simple soaking technique. It was shown that 100 mg of the HA polymer disk could load up to 278 μg (55.6%) of LL37-HABP. Evaluation of the cytotoxic properties of the designed fusion peptide before and after immobilization on HA polymer disks against C2C12 cells showed that immobilization resulted in the reduction of HABP-LL37 cytotoxicity. The use of this bi-functional peptide with HA-based biomaterial can result in the development of novel and safe antimicrobial bone substitutes to manage and reduce the complications of device infection.
               
Click one of the above tabs to view related content.